These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4204490)

  • 1. Immunogenicity of purified, inactivated chikungunya virus in monkeys.
    Nakao E; Hotta S
    Bull World Health Organ; 1973 May; 48(5):559-62. PubMed ID: 4204490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of immunogenic potential of Vero adapted formalin inactivated vaccine derived from novel ECSA genotype of Chikungunya virus.
    Tiwari M; Parida M; Santhosh SR; Khan M; Dash PK; Rao PV
    Vaccine; 2009 Apr; 27(18):2513-22. PubMed ID: 19368794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chikungunya virus vaccine prepared by Tween-ether extraction.
    Eckels KH; Harrison VR; Hetrick FM
    Appl Microbiol; 1970 Feb; 19(2):321-5. PubMed ID: 4985431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virus.
    Kumar M; Sudeep AB; Arankalle VA
    Vaccine; 2012 Sep; 30(43):6142-9. PubMed ID: 22884660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys.
    Putnak R; Barvir DA; Burrous JM; Dubois DR; D'Andrea VM; Hoke CH; Sadoff JC; Eckels KH
    J Infect Dis; 1996 Dec; 174(6):1176-84. PubMed ID: 8940206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative immunogenicities of Chikungunya vaccines propagated in monkey kidney monolayers and chick embryo suspension cultures.
    White A; Berman S; Lowenthal JP
    Appl Microbiol; 1972 May; 23(5):951-2. PubMed ID: 4624213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218.
    Edelman R; Tacket CO; Wasserman SS; Bodison SA; Perry JG; Mangiafico JA
    Am J Trop Med Hyg; 2000 Jun; 62(6):681-5. PubMed ID: 11304054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an attenuated strain of chikungunya virus for use in vaccine production.
    Levitt NH; Ramsburg HH; Hasty SE; Repik PM; Cole FE; Lupton HW
    Vaccine; 1986 Sep; 4(3):157-62. PubMed ID: 3020820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production and evaluation of a formalin-killed Chikungunya vaccine.
    Harrison VR; Eckels KH; Bartelloni PJ; Hampton C
    J Immunol; 1971 Sep; 107(3):643-7. PubMed ID: 4999088
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunogenicity and protective efficacy in mice of a formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells.
    Appaiahgari MB; Vrati S
    Vaccine; 2004 Sep; 22(27-28):3669-75. PubMed ID: 15315846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radial haemolysis in gel: a comparative study with Chikungunya, Japanese encephalitis and rubella viruses, representatives of three genera of Togaviridae family.
    Gaidamovich SY; Melnikova EE; Väänänen P; Penttinen K
    Arch Virol; 1980; 64(4):339-47. PubMed ID: 6994690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunogenic properties of A2/Hongkong/1/68 influenza virus inactivated with gamma rays].
    Kulevich EE; Kosiakov PN
    Vopr Virusol; 1974; (6):696-700. PubMed ID: 4446569
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of a micro-neutralization test for chikungunya virus.
    Raharjo E; Tadano M; Okamoto Y; Okuno Y
    Biken J; 1986 Mar; 29(1):27-30. PubMed ID: 3022710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical, chemical and morphologic dimensions of human hepatitis A virus strain CR326 (38578).
    Provost PJ; Wolanski BS; Miller WJ; Ittensohn OL; McAleer WJ; Hilleman MR
    Proc Soc Exp Biol Med; 1975 Feb; 148(2):532-9. PubMed ID: 164674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation of chikungunya virus contaminating an Aedes albopictus cell line.
    Cunningham A; Buckley SM; Casals J; Webb SR
    J Gen Virol; 1975 Apr; 27(1):97-100. PubMed ID: 806659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the antigenic and immunogenic properties of neurovaccinia virus TS mutants.
    Chernos VI; Vasilieva NN; Antonova TP; Surgay VV
    Arch Virol; 1975; 47(2):89-96. PubMed ID: 1119943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of viremia and antibody observed in rhesus monkeys inoculated with chikungunya and other serologically related group A arboviruses.
    Binn LN; Harrison VR; Randall R
    Am J Trop Med Hyg; 1967 Nov; 16(6):782-5. PubMed ID: 4965218
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on simian viruses as possible contaminants of inactivated virus vaccines. I. Direct and serologic detection of simian adenovirus SV20 (author's transl)].
    von Mettenheim AE
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):131-40. PubMed ID: 1179876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant CHIK virus E1 coat protein of 11 KDa with antigenic domains for the detection of Chikungunya.
    Yathi KK; Joseph JM; Bhasker S; Kumar R; Chinnamma M
    J Immunol Methods; 2011 Sep; 372(1-2):171-6. PubMed ID: 21798263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of an antirabies vaccine from sheep brain tissue inactivated by UV rays (author's transl)].
    Pospeeva NA; Morogova VM; Gil'dina SS; Nikolaeva NV; Losev MN
    Vopr Virusol; 1975; (5):578-81. PubMed ID: 1210319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.